Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $890 | $425 | $77 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $207 | $154 | $37.7K | $2.4K | $0 | $0 |
| Gross profit | $0 | $0 | $683 | $271 | −$37.6K | −$2.4K | $0 | $0 |
| Gross margin | — | — | 76.7% | 63.8% | -48837.7% | — | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$155.0K | −$461.0K | −$351.0K | −$316.0K | −$304.0K | −$9.1M | −$1.3M | −$1.9M |
| EBITDA | −$2.8M | −$583.0K | −$713.0K | −$314.0K | −$302.0K | −$9.1M | −$1.3M | $6.7K |
| Net income | −$3.3M | −$1.7M | −$817.0K | −$675.0K | −$542.0K | −$9.8M | −$1.5M | −$1.9M |
| Net margin | — | — | -91797.8% | -158823.5% | -703896.1% | — | — | — |
| EPS (diluted) | -0.12 | -0.04 | -0.01 | -0.02 | -0.00 | -0.02 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
GLOBESTAR THERAPEUTICS CO
No one on the platform currently holds GSTC.
No tracked institution reports a position in GSTC as of their last filing.
No one on the platform has traded GSTC yet.
| $10127 |
| — |
| GBLXGB Sciences, Inc. | $0.00 | +33.33% | $162828 | — |
| HTDSHard to Treat Diseases Inc. | $0.00 | +0.00% | $109647 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$GSTC my step mom was recently diagnosed with MS. I'm rooting for a W here.
View on StockTwits ↗$GSTC Downward pressure is gone... news coming?
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.